Neurological criteria for drug-resistance in epilepsy
Vercueil, L.
Revue Neurologique (Paris) 160(Special Issue 1): 5s60-5s64
2004
ISSN/ISBN: 0035-3787 PMID: 15331950 Document Number: 566917
Drug-resistance is widely considered as a prerequisite for any surgical treatment in epilepsy. It is however noteworthy that an international consensus regarding the definition of this pharmacological concept, or, at least, detailing the criteria required for the diagnosis, is lacking. Based on a systematic review of the literature, we discuss the proposed definitions in expert's position papers or used in controlled or multicentric studies. A check-list for the diagnosis of drug-resistant epilepsy is proposed.
Document emailed within 1 workday
Related Documents
de Saint-Martin, A.; Hirsch, E. 2004: Refractory partial epilepsy: what are the neuropediatrician's criteria for drug resistance? Revue Neurologique (Paris) 160(Special Issue 1): 5s43-5s47Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396
Mbacham, W.; Njikam, N. 2007: Marqueurs moléculaires de résistance aux médicaments antipaludiques : Nécessaires mais pas suffisants pour un changement de politique de santé - Molecular markers for malaria drug resistance : Necessary but not sufficient criteria to decide change in treatment policy Medecine Tropicale 67(2): 183-187
Heinemann, U.; Kann, O.; Remy, S.; Beck, H. 2006: Novel mechanisms underlying drug resistance in temporal lobe epilepsy Advances in Neurology 97: 85-95
Egewarth, C.; Pires, F.D.A.; Guardiola, A. 2002: Assessment of gestational age of preterm newborn based on neurological examination, obstetric dating criteria and pediatrics criteria Arquivos de Neuro-Psiquiatria 60(3-B): 755-759
Serrano-Castro, P.J.; Ramos-Lizana, J.; Pita-Calandre, E.; Camino-León, R.; Galán-Barranco, J.M.; Rufo-Campos, M.; Moreno-Alegre, V.; Altuzarra-Corral, A.; Casado-Chocán, J.L.; Mercadá-Cerdá, J.M.; Sánchez-Alvarez, J.C. 2005: The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: I. Criteria for starting and discontinuing and the pharmacological bases of antiepileptic treatment Revista de Neurologia 40(9): 563-571
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Thaweepoksomboon, J.; Chinvarun, Y.; Sakoolnamarka, S.; Udommongkol, C.; Sithinamsuwan, P. 2016: Global Outcomes of Epilepsy Surgery in Drug-Resistant Focal Epilepsy: a Longitudinal Survey Journal of the Medical Association of Thailand 99(7): 764-771
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Russell, A.; Hanscomb, A. 1997: Epilepsy: the most common serious neurological condition Nursing Times 93(21): 52-55
Zulley, J.; Binnie, C.; Russell, M. 2000: GPS and neurological practice in sleep, headache and epilepsy Studies in Health Technology and Informatics 78: 15-43
Towanabut, S.; Chulavatnatol, S.; Suthisisang, C.; Wanakamanee, U. 1998: The period prevalence of catamenial epilepsy at Prasat Neurological Institute, Bangkok Journal of the Medical Association of Thailand 81(12): 970-977
Janszky, J.óz. 2009: Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases Ideggyogyaszati Szemle 62(11-12): 383-389
Kaminskiĭ, S.N. 1988: Criteria for assessing the reliability and information value of diagnostic data in neurological studies Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(7): 102-104
Glötzner, F.L. 1987: Diagnosis and selection criteria of surgical therapy of epilepsy Der Nervenarzt 58(9): 531-537
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Ishihara, H. 2011: Treatment for exacerbation--drug and non-drug therapy, criteria of hospitalization and ICU admission Nihon Rinsho. Japanese Journal of Clinical Medicine 69(10): 1863-1868
Umićević, P.; Dordević, D.; Radulović, S.; Dulić, S.; Veljković, D. 1989: Criteria for the diagnosis of epilepsy caused by cerebral cysticercosis in a population of recruits Vojnosanitetski Pregled 46(6): 420-427